Cargando…

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study

BACKGROUND: Rifaximin effectively treats symptomatic uncomplicated diverticular disease (SUDD) and has shown eubiotic potential (i.e., an increase in resident microbial elements with potential beneficial effects) in other diseases. This study investigated changes in the fecal microbiome of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivashkin, Vladimir, Shifrin, Oleg, Maslennikov, Roman, Poluektova, Elena, Korolev, Alexander, Kudryavtseva, Anna, Krasnov, George, Benuni, Nona, Barbara, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037807/ https://www.ncbi.nlm.nih.gov/pubmed/36959568 http://dx.doi.org/10.1186/s12876-023-02690-x

Ejemplares similares

Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management
por: Maconi, Giovanni
Publicado: (2017)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Faecalibacterium prausnitzii is not decreased in symptomatic uncomplicated diverticular disease of the colon
por: TURSI, Antonio, et al.
Publicado: (2022)

Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy
por: De Vincentis, Antonio, et al.
Publicado: (2021)

Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
por: Pietrzak, Anna M., et al.
Publicado: (2019)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
por: Cianci, Rossella, et al.
Publicado: (2014)

Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease
por: Maconi, Giovanni, et al.
Publicado: (2023)

Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Piccin, Anna, et al.
Publicado: (2023)

Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review
por: Carabotti, Marilia, et al.
Publicado: (2017)

Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease
por: Altomare, Annamaria, et al.
Publicado: (2021)

Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management
por: Calini, Giacomo, et al.
Publicado: (2023)

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort
por: Lahat, Adi, et al.
Publicado: (2020)

The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study
por: Tursi, Antonio, et al.
Publicado: (2021)

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
por: Ivashkin, Vladimir, et al.
Publicado: (2021)

Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of Curcuma longa and Boswellia serrata extracts
por: Giacosa, Attilio, et al.
Publicado: (2020)

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome
por: Ivashkin, V., et al.
Publicado: (2021)

Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022)

Human Blood Bacteriome: Eubiotic and Dysbiotic States in Health and Diseases
por: Suparan, Kanokphong, et al.
Publicado: (2022)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
por: Ivashkin, Vladimir T., et al.
Publicado: (2022)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Probiotics in hepatology: An update
por: Maslennikov, Roman, et al.
Publicado: (2021)

Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

A critical role of a eubiotic microbiota in gating proper immunocompetence in Arabidopsis
por: Paasch, Bradley C., et al.
Publicado: (2023)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Dietary Supplementation of Eubiotic Fiber Based on Lignocellulose on Performance and Welfare of Gestating and Lactating Sows
por: Odakura, Agnês Markiy, et al.
Publicado: (2023)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Dos ataques de diarrea consecutivos en 15 pacientes de COVID-19: uno asociado con antibióticos posterior a uno viral
por: Maslennikov, R., et al.
Publicado: (2022)

Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one()
por: Maslennikov, R., et al.
Publicado: (2022)

Eubiotic effect of a dietary acidifier (potassium diformate) on the health status of cultured Oreochromis niloticus
por: Abu Elala, Nermeen M., et al.
Publicado: (2015)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Usefulness of EndoFLIP in Diverticular Peroral Endoscopic Myotomy for Symptomatic Epiphrenic Diverticulum
por: Noh, Jin Hee, et al.
Publicado: (2023)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1ab4l5i34ida7bjsirco35u4f